CymaBay Therapeutics to Report First Quarter 2020 Financial Results on Monday, May 11

Rhea-AI Summary

CymaBay Therapeutics, Inc. (NASDAQ: CBAY) announced a conference call on May 11, 2020, at 4:30 p.m. ET to discuss its financial results for Q1 2020, which ended on March 31, 2020. The call will provide an update on the company's business as it focuses on developing therapies for liver and other chronic diseases.

Investors can access the call by dialing specific numbers provided or through the company's website for a live and archived audio webcast.

Positive

• Scheduled conference call to discuss Q1 financial results and business update indicates transparency to shareholders.

Negative

• None.

News Market Reaction – CBAY

+1.11%

+1.11% Session move

In the trading session that priced this news, CBAY gained 1.11%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NEWARK, Calif., May 04, 2020 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, today announced that it will host a conference call and live audio webcast on Monday, May 11, 2020 at 4:30 p.m. Eastern Time to discuss financial results for the first quarter ended March 31, 2020 and to provide a business update.

Conference Call Details
To access the live conference call, please dial 855-327-6837 from the U.S. and Canada, or 631-891-4304 internationally, Conference ID# 10009543. To access the live and subsequently archived webcast of the conference call, go to the Investors section of the company's website at http://ir.cymabay.com/events.

About CymaBay

CymaBay Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet medical need.

For additional information about CymaBay visit www.cymabay.com.

Contact:
Sloane & Company
Dan Zacchei / Joe Germani, 212-486-9500
Dzacchei@sloanepr.com / JGermani@sloanepr.com

FAQ

When is CymaBay's Q1 2020 conference call?

CymaBay's Q1 2020 conference call is scheduled for May 11, 2020, at 4:30 p.m. ET.

How can I access CymaBay's conference call?

You can access the conference call by dialing 855-327-6837 from the U.S. or 631-891-4304 internationally, using Conference ID# 10009543, or by visiting the Investors section of the CymaBay website.

What financial period will CymaBay discuss during the call?

CymaBay will discuss its financial results for the first quarter ended March 31, 2020.